Radioiodine treatment outcomes in thyroid glands previously irradiated for Graves' hyperthyroidism

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 712-716

  Leslie, William D ^a,b   Peterdy, Anne E ^a   Dupont, Jacqueline O ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Graves' disease; Hyperthyroidism; Iodine 131

Indexed keywords

IODINE 131;

ARTICLE; DOSIMETRY; FOLLOW UP; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIODINATION; RADIOSENSITIVITY; RISK BENEFIT ANALYSIS; TREATMENT FAILURE;

GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MULTIVARIATE ANALYSIS; RECURRENCE; RETREATMENT; RETROSPECTIVE STUDIES; THYROID GLAND; TREATMENT OUTCOME;

EID: 0031900686     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ross DS. Current therapeutic approaches to hyperthyroidism. Trends Endocrinol Metab 1993;4:281-285.
2. 131I therapy for Graves' disease. N Engl J Med 1984;311:426-432.
3. Kung AWC, Choi P, Lam KSL, Pun KK, Wang C, Yeung RTT. Discriminant factors affecting early outcome of radioiodine treatment for Graves' disease. Clin Radiol 1990;42:52-54.
4. 131I treatment protocols for Graves' disease. J Endocrinol Invest 1990;13:111-118.
5. Ratcliffe GE, Fogelman I, Maisey MN. The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. Br J Radiol 1986;59:1105-1107.
6. 131I therapy for Graves' disease. Clin Endocrinol (Oxf) 1988;28:487-496.
7. Nordyke RA, Gilbert FI, Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991;32:411-416.
8. Harbert JC. Radioiodine therapy of hyperthyroidism. In: Harbert JC, Eckelman WC, eds. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishers; 1996:951-973.
9. Hayes AA, Akre CM, Gorman CA. Iodine-131 of Graves' disease using modified early iodine-131 uptake measurements in therapy dose calculations. J Nucl Med 1990;31: 519-522.
10. Hennessey JV, Berg LA, Ibrahim MA, Markert RJ. Evaluation of early (5-6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves' disease. Arch Intern Med 1995;155:621-624.
11. 131I treatment for Graves' disease in Hong Kong Chinese - discriminant factors predicting hypothyroidism. Q J Med 1990;76:961-967.
12. Goolden AWG, Stewart JSW. Long-term results from graded low dose radioactive iodine therapy for thyrotoxicosis. Clin Endocrinol 1986;24:217-222.
13. Berglund J, Christensen SB, Dymling JF, Hallengren B. The incidence of recurrence and hypothyroidism following treatment with antithyroid drugs, surgery or radioiodine in all patients with thyrotoxicosis in Malmo during the period 1970-1974. J Intern Med 1991;229:435-442.
14. 131I in treatment of Graves' disease. J R Soc Med 1985;78:197-202.
15. Törring O, Tallstedt L, Wallin G, et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective randomized study. J Clin Endocrinol Metab 1996;81:2986-2993.
16. Willemsen UF, Knesewitsch P, Kreisig T, Pickardt CR, Kirsch CM. Functional results of radioiodine therapy with a 300-Gy absorbed dose in Graves' disease. Eur J Nucl Med 1993;20:1051-1055.
17. Hardisty CA, Jones SJ, Hedley AJ, Munro DS, Bewsher PD, Weir RD. Clinical outcome and costs of care in radioiodine treatment of hyperthyroidism. J R Coll Physicians Lond 1990;24:36-42.
18. De Bruin TWA, Croon CDL, De Klerk JMH, Van Isselt JW. Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J Intern Med 1994;236:507-513.
19. 131I therapy. Br Med J 1960;1:151-154.
20. Connell JMC, Hilditch TE, Robertson J, Coghill G, Alexander WD. Radioprotective action of carbimazole in radioiodine therapy for thyrotoxicosis - influence of the drug on iodine kinetics. Eur J Nucl Med 1987;13:358-361.
21. Velkeniers B, Cytryn R, Vanhaelst L, Jonckheer MH. Treatment of hyperthyroidism with radioiodine: adjunctive therapy with antithyroid drugs reconsidered. Lancet 1988;i;1127-1129.
22. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1989;70:1518-1522.
23. 131I therapy: the small pool syndrome. J Nucl Med 1973;14:79.
24. 131: continuation of antithyroid drugs does not adversely affect therapy and in "small pool" patients reduces the extrathyroidal radiation dose. In: Gordon A, Gross J, Henneman G, eds. Progress in thyroid research. Rotterdam, The Netherlands: Balkema; 1991:223-226.
25. Aktay R, Rezai K, Seabold JE, Bar RS, Kirchner PT. Four- to twenty-four-hour uptake ratio: an index of rapid iodine-131 turnover in hyperthyroidism. J Nucl Med 1996;37:1815-1819.